Sutton Place Investors’s AbbVie ABBV Stock Holding History

Sutton Place Investors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$261K	Sell	1,202 -7	-0.6%	-$1.55K	0.14%	113
2025 Q4	$276K	Buy	1,209 +61	+5%	+$13.9K	0.15%	109
2025 Q3	$266K	Buy	+1,148	New	+$234K	0.15%	108
2025 Q2	–	Sell	-1,084	Closed	-$227K	–	119
2025 Q1	$227K	Sell	1,084 -1,483	-58%	-$288K	0.15%	102
2024 Q4	$456K	Buy	2,567 +27	+1%	+$4.96K	0.26%	81
2024 Q3	$502K	Buy	2,540 +138	+6%	+$25.8K	0.31%	73
2024 Q2	$412K	Sell	2,402 -31	-1%	-$5.13K	0.27%	77
2024 Q1	$443K	Buy	+2,433	New	+$419K	0.22%	111

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sutton Place Investors's ABBV Position: Q1 2026 in Review

Sutton Place Investors reduced its AbbVie (ABBV) stake by 0.58% in Q1 2026, selling an estimated $1.55K and leaving 1,202 shares worth $261K. The position accounts for 0.14% of the portfolio, ranked #113.

Sutton Place Investors first reported a position in ABBV in Q1 2024 and has held it in 8 quarters since. The position peaked at $502K in Q3 2024. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Sutton Place Investors held 1,202 shares of AbbVie worth $261K as of Q1 2026.
Sutton Place Investors sold 7 AbbVie shares in Q1 2026, an estimated $1.55K.
AbbVie made up 0.14% of Sutton Place Investors's portfolio in Q1 2026, its #113 holding.
Sutton Place Investors first reported a position in AbbVie in Q1 2024 and has held it in 8 quarters since.
Sutton Place Investors's AbbVie position peaked at $502K in Q3 2024.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Sutton Place Investors's 13F filing for Q1 2026, filed 22 Apr 2026.